Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Special collections
JITC
Commentary/Editorials
Email alerts
Commentary/Editorials
Response of primary tumor and lymph node in non-small cell lung cancer after neoadjuvant immunotherapy: a pooled analysis
Wen-Yu
Zhai
,
Ze-Rui
Zhao
,
Si
Chen
,
Hui
Yu
,
Yao-Bin
Lin
,
Yi-Zhi
Wang
,
Hao
Long
Journal for ImmunoTherapy of Cancer
Sep 2022,
10
(9)
e005160;
DOI:
10.1136/jitc-2022-005160
High antigen density of BCMA: friend or foe to CAR T cells?
Mahmoud R
Gaballa
,
Marcela V
Maus
Journal for ImmunoTherapy of Cancer
Sep 2022,
10
(9)
e005822;
DOI:
10.1136/jitc-2022-005822
Ironing out exercise on immuno-oncological outcomes
Janjira
Soh
,
Zi Xiang
Lim
,
Elaine Hsuen
Lim
,
Brian K
Kennedy
,
Jorming
Goh
Journal for ImmunoTherapy of Cancer
Sep 2022,
10
(9)
e002976;
DOI:
10.1136/jitc-2021-002976
Celebrating a decade of the
Journal for ImmunoTherapy of Cancer
Pedro J
Romero
,
James L
Gulley
,
Patrick
Hwu
,
Mary
Dean
,
Samuel
Million-Weaver
Journal for ImmunoTherapy of Cancer
May 2022,
10
(5)
e005207;
DOI:
10.1136/jitc-2022-005207
Perspectives on imaging and immunotherapy: a review series
Elisabeth GE
de Vries
,
Lawrence H
Schwartz
Journal for ImmunoTherapy of Cancer
Jun 2022,
10
(6)
e005006;
DOI:
10.1136/jitc-2022-005006
Sonic hedgehog pathway for the treatment of inflammatory diseases: implications and opportunities for future research
Marco
Palla
,
Luigi
Scarpato
,
Rossella
Di Trolio
,
Paolo Antonio
Ascierto
Journal for ImmunoTherapy of Cancer
Jun 2022,
10
(6)
e004397;
DOI:
10.1136/jitc-2021-004397
Resistance to systemic immune checkpoint inhibition in the peritoneal niche
Daryl Kai Ann
Chia
,
Yong Xiang
Gwee
,
Raghav
Sundar
Journal for ImmunoTherapy of Cancer
Jun 2022,
10
(6)
e004749;
DOI:
10.1136/jitc-2022-004749
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development
Hussein A
Tawbi
,
Ryan J
Sullivan
,
David
Feltquate
,
Theresa
LaVallee
,
Naiyer A
Rizvi
,
Elad
Sharon
,
Jeffrey
Sosman
,
Harriet M
Kluger
Journal for ImmunoTherapy of Cancer
Jul 2023,
11
(7)
e007309;
DOI:
10.1136/jitc-2023-007309
Commentary on oncolytic viruses: past, present, and future
Christopher
Larson
,
Bryan
Oronsky
,
Tony R
Reid
Journal for ImmunoTherapy of Cancer
Dec 2023,
11
(12)
e007905;
DOI:
10.1136/jitc-2023-007905
Adjuvant therapy in completely resected, EGFR-mutant non-small cell lung cancer: a comparative analysis of treatment efficacy between EGFR-TKI and anti-PD-1/PD-L1 immunotherapy
Zichun
Li
,
Xuanye
Zhang
,
Yuhong
Wang
,
Zhixin
Yu
,
Chunlong
Yang
,
Yixin
Zhou
,
Shaodong
Hong
Journal for ImmunoTherapy of Cancer
Oct 2023,
11
(10)
e007327;
DOI:
10.1136/jitc-2023-007327
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
Special collections
COVID-19
(44)
Editor's choice
JITC
Basic Tumor Immunology
(538)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(940)
Commentary/Editorials
(142)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(54)
Guidelines and Consensus Statements
(50)
Imaging and Immunotherapy
(8)
Immune Cell Therapies and Immune Cell Engineering
(213)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(405)
Liquid Biopsies
(9)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(143)
Reviews
(239)
Open access
(4867)
Press releases